Skip to main content
Top
Published in: European Radiology 7/2021

01-07-2021 | Magnetic Resonance Imaging | Gastrointestinal

Regional liver function analysis with gadoxetic acid–enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC

Authors: Mengqi Huang, Shunli Shen, Huasong Cai, Zhenpeng Peng, Wan Hang Keith Chiu, Zi-Ping Li, Baogang Peng, Shi-Ting Feng

Published in: European Radiology | Issue 7/2021

Login to get access

Abstract

Objectives

To explore the role of quantitative regional liver function assessed by preoperative gadoxetic acid–enhanced MRI with computer-aided virtual hepatectomy to predict short-term outcomes after major hepatectomy for HCC.

Methods

We retrospectively reviewed the records of 133 consecutive patients with HCC who underwent preoperative gadoxetic acid–enhanced MRI and indocyanine green (ICG) test. Forty-five patients received open major hepatectomy. Liver function reserve and the future liver remnant were evaluated by computer-aided virtual hepatectomy. Global liver functional parameters included the T1 relaxation time reduction rate (T1ratio) and functional liver volume (FV), whereas regional parameters included the rT1pos, rT1ratio, remnant FV (rFV), and remnant FV ratio (rFVratio) of the remnant liver. The functional parameters of the MRI and ICG were used to predict the short-term outcomes (liver failure and major complications) after major hepatectomy.

Results

The T1ratio and FV were correlated with the ICG test (rho = − 0.304 and − 0.449, p < 0.05). FV < 682.8 ml indicated preoperative ICG-R15 ≥ 14% with 0.765 value of the area under the curve (AUC). No patient who underwent major resection with good liver functional reserve (ICG < 14%) and enough future remnant volume (> 30% standard LV) developed liver failure. Low rT1ratio (< 66.5%) and high rT1pos (> 217.5 ms) may predict major complications (AUC = 0.831 and 0.756, respectively; p < 0.05). The rT1ratio was an independent risk factor for postoperative major complications (odds ratio [OR] = 0.845, 95% CI, 0.736–0.966; p < 0.05).

Conclusion

Preoperative gadoxetic acid–enhanced MRI with computer-aided virtual hepatectomy may facilitate optimal assessment of regional liver functional reserve to predict short-term outcomes after major hepatectomy for HCC.

Key Points

Preoperative gadoxetic acid–enhanced MRI with virtual hepatectomy and volumetric analysis can provide precise liver volume and regional functional assessment.
Quantitative regional liver function assessed by gadoxetic acid–enhanced MRI can predict the short-term outcomes after major hepatectomy in patients with HCC.
The regional liver function assessed by gadoxetic acid–enhanced MRI is an independent risk factor for postoperative major complications.
Literature
1.
go back to reference Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386PubMedCrossRef Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386PubMedCrossRef
2.
go back to reference Bruix J, Sherman M, American Association for the Study of Liver Diseases (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022PubMedCrossRef Bruix J, Sherman M, American Association for the Study of Liver Diseases (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022PubMedCrossRef
3.
go back to reference Forner A, Reig ME, deLope CR, Bruix J (2010) Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 30:61–74PubMedCrossRef Forner A, Reig ME, deLope CR, Bruix J (2010) Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 30:61–74PubMedCrossRef
4.
go back to reference Vogel A, Cervantes A, Chau I et al (2018) Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29:iv238–iv255PubMedCrossRef Vogel A, Cervantes A, Chau I et al (2018) Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29:iv238–iv255PubMedCrossRef
5.
go back to reference European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRef European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRef
6.
go back to reference Wong TC, Lo CM (2013) Resection strategies for hepatocellular carcinoma. Semin Liver Dis 33:273–281PubMedCrossRef Wong TC, Lo CM (2013) Resection strategies for hepatocellular carcinoma. Semin Liver Dis 33:273–281PubMedCrossRef
7.
go back to reference Sato M, Tateishi R, Yasunaga H et al (2012) Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol 47:1125–1133PubMedCrossRef Sato M, Tateishi R, Yasunaga H et al (2012) Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma: a national survey of 54,145 patients. J Gastroenterol 47:1125–1133PubMedCrossRef
8.
go back to reference Kehlet H, Wilmore DW (2008) Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg 248:189–198PubMedCrossRef Kehlet H, Wilmore DW (2008) Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg 248:189–198PubMedCrossRef
9.
go back to reference Chen Q, Beal EW, Kimbrough CW et al (2018) Perioperative complications and the cost of rescue or failure to rescue in hepato-pancreato-biliary surgery. HPB (Oxford) 20:854–864CrossRef Chen Q, Beal EW, Kimbrough CW et al (2018) Perioperative complications and the cost of rescue or failure to rescue in hepato-pancreato-biliary surgery. HPB (Oxford) 20:854–864CrossRef
10.
go back to reference Steffens D, Beckenkamp PR, Hancock M, Solomon M, Young J (2018) Preoperative exercise halves the postoperative complication rate in patients with lung cancer: a systematic review of the effect of exercise on complications, length of stay and quality of life in patients with cancer. Br J Sports Med 52:344 Steffens D, Beckenkamp PR, Hancock M, Solomon M, Young J (2018) Preoperative exercise halves the postoperative complication rate in patients with lung cancer: a systematic review of the effect of exercise on complications, length of stay and quality of life in patients with cancer. Br J Sports Med 52:344
11.
go back to reference Huang TH, Hsieh CC, Kuo LM et al (2019) Malnutrition associated with an increased risk of postoperative complications following hepatectomy in patients with hepatocellular carcinoma. HPB (Oxford) 21:1150–1155CrossRef Huang TH, Hsieh CC, Kuo LM et al (2019) Malnutrition associated with an increased risk of postoperative complications following hepatectomy in patients with hepatocellular carcinoma. HPB (Oxford) 21:1150–1155CrossRef
12.
go back to reference Prodeau M, Drumez E, Duhamel A et al (2019) An ordinal model to predict the risk of symptomatic liver failure in patients with cirrhosis undergoing hepatectomy. J Hepatol 71:920–929PubMedCrossRef Prodeau M, Drumez E, Duhamel A et al (2019) An ordinal model to predict the risk of symptomatic liver failure in patients with cirrhosis undergoing hepatectomy. J Hepatol 71:920–929PubMedCrossRef
13.
go back to reference Tsilimigras DI, Hyer JM, Moris D et al (2019) Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: a multi-institutional analysis of 706 patients. J Surg Oncol 120:206–213PubMed Tsilimigras DI, Hyer JM, Moris D et al (2019) Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: a multi-institutional analysis of 706 patients. J Surg Oncol 120:206–213PubMed
14.
go back to reference Lim C, Dejong CH, Farges O, e-HPBchir Study Group from the Association de Chirurgie Hépato-Biliaire et de Transplantation (ACHBT) (Association of Hepatobilary and Transplant Surgery) (2015) Improving the quality of liver resection: a systematic review and critical analysis of the available prognostic models. HPB (Oxford) 17:209–221CrossRef Lim C, Dejong CH, Farges O, e-HPBchir Study Group from the Association de Chirurgie Hépato-Biliaire et de Transplantation (ACHBT) (Association of Hepatobilary and Transplant Surgery) (2015) Improving the quality of liver resection: a systematic review and critical analysis of the available prognostic models. HPB (Oxford) 17:209–221CrossRef
15.
go back to reference Yang T, Zhang J, Lu JH, Yang GS, Wu MC, Yu WF (2011) Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg 35:2073–2082PubMedCrossRef Yang T, Zhang J, Lu JH, Yang GS, Wu MC, Yu WF (2011) Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg 35:2073–2082PubMedCrossRef
16.
go back to reference Golriz M, Ghamarnejad O, Khajeh E et al (2018) Preoperative thrombocytopenia may predict poor surgical outcome after extended hepatectomy. Can J Gastroenterol Hepatol 2018:1275720PubMedPubMedCentralCrossRef Golriz M, Ghamarnejad O, Khajeh E et al (2018) Preoperative thrombocytopenia may predict poor surgical outcome after extended hepatectomy. Can J Gastroenterol Hepatol 2018:1275720PubMedPubMedCentralCrossRef
17.
go back to reference Yokoyama Y, Ebata T, Igami T et al (2016) The predictive value of indocyanine green clearance in future liver remnant for posthepatectomy liver failure following hepatectomy with extrahepatic bile duct resection. World J Surg 40:1440–1447PubMedCrossRef Yokoyama Y, Ebata T, Igami T et al (2016) The predictive value of indocyanine green clearance in future liver remnant for posthepatectomy liver failure following hepatectomy with extrahepatic bile duct resection. World J Surg 40:1440–1447PubMedCrossRef
18.
go back to reference Wibmer A, Prusa AM, Nolz R, Gruenberger T, Schindl M, Ba-Ssalamah A (2013) Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging. Radiology 269:777–786PubMedCrossRef Wibmer A, Prusa AM, Nolz R, Gruenberger T, Schindl M, Ba-Ssalamah A (2013) Liver failure after major liver resection: risk assessment by using preoperative Gadoxetic acid-enhanced 3-T MR imaging. Radiology 269:777–786PubMedCrossRef
19.
go back to reference van der Velden S, Braat MNGJA, Labeur TA et al (2019) A pilot study on hepatobiliary scintigraphy to monitor regional liver function in 90 Y radioembolization. J Nucl Med 60:1430–1436PubMedPubMedCentralCrossRef van der Velden S, Braat MNGJA, Labeur TA et al (2019) A pilot study on hepatobiliary scintigraphy to monitor regional liver function in 90 Y radioembolization. J Nucl Med 60:1430–1436PubMedPubMedCentralCrossRef
20.
go back to reference Yoon JH, Choi JI, Jeong YY et al (2016) Pre-treatment estimation of future remnant liver function using gadoxetic acid MRI in patients with HCC. J Hepatol 65:1155–1162PubMedCrossRef Yoon JH, Choi JI, Jeong YY et al (2016) Pre-treatment estimation of future remnant liver function using gadoxetic acid MRI in patients with HCC. J Hepatol 65:1155–1162PubMedCrossRef
21.
go back to reference Kim HD, Lim YS, Han S et al (2015) Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival. Gastroenterology 148:1371–1382PubMedCrossRef Kim HD, Lim YS, Han S et al (2015) Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival. Gastroenterology 148:1371–1382PubMedCrossRef
22.
go back to reference Mise Y, Hasegawa K, Satou S et al (2018) How has virtual hepatectomy changed the practice of live surgery?: Experience of 1194 virtual hepatectomy before liver resection and living donor liver transplantation. Ann Surg 268:127–133PubMedCrossRef Mise Y, Hasegawa K, Satou S et al (2018) How has virtual hepatectomy changed the practice of live surgery?: Experience of 1194 virtual hepatectomy before liver resection and living donor liver transplantation. Ann Surg 268:127–133PubMedCrossRef
23.
go back to reference Van Beers BE, Pastor CM, Hussain HK (2012) Primovist, Eovist: what to expect? J Hepatol 57:421–429PubMedCrossRef Van Beers BE, Pastor CM, Hussain HK (2012) Primovist, Eovist: what to expect? J Hepatol 57:421–429PubMedCrossRef
24.
go back to reference Clavien PA, Petrowsky H, DeOliveira ML, Graf R (2007) Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 356:1545–1559PubMedCrossRef Clavien PA, Petrowsky H, DeOliveira ML, Graf R (2007) Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 356:1545–1559PubMedCrossRef
25.
go back to reference Paugam-Burtz C, Janny S, Delefosse D et al (2009) Prospective validation of the “fifty-fifty” criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg 249:124–128PubMedCrossRef Paugam-Burtz C, Janny S, Delefosse D et al (2009) Prospective validation of the “fifty-fifty” criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg 249:124–128PubMedCrossRef
26.
go back to reference Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedPubMedCentralCrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedPubMedCentralCrossRef
28.
go back to reference Yoon JH, Lee JM, Kang HJ et al (2019) Quantitative assessment of liver function by using gadoxetic acid–enhanced MRI: hepatocyte uptake ratio. Radiology 290:125–133PubMedCrossRef Yoon JH, Lee JM, Kang HJ et al (2019) Quantitative assessment of liver function by using gadoxetic acid–enhanced MRI: hepatocyte uptake ratio. Radiology 290:125–133PubMedCrossRef
29.
go back to reference Nakagawa M, Namimoto T, Shimizu K et al (2017) Measuring hepatic functional reserve using T1 mapping of Gd-EOB-DTPA enhanced 3T MR imaging: a preliminary study comparing with 99m Tc GSA scintigraphy and signal intensity based parameters. Eur J Radiol 92:116–123PubMedCrossRef Nakagawa M, Namimoto T, Shimizu K et al (2017) Measuring hepatic functional reserve using T1 mapping of Gd-EOB-DTPA enhanced 3T MR imaging: a preliminary study comparing with 99m Tc GSA scintigraphy and signal intensity based parameters. Eur J Radiol 92:116–123PubMedCrossRef
30.
go back to reference de Graaf W, Häusler S, Heger M et al (2011) Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green. J Hepatol 54:738–745PubMedCrossRef de Graaf W, Häusler S, Heger M et al (2011) Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green. J Hepatol 54:738–745PubMedCrossRef
31.
go back to reference Krieger PM, Tamandl D, Herberger B et al (2011) Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing. Ann Surg Oncol 18:1644–1650PubMedCrossRef Krieger PM, Tamandl D, Herberger B et al (2011) Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing. Ann Surg Oncol 18:1644–1650PubMedCrossRef
32.
go back to reference Poon RT, Fan ST (2005) Assessment of hepatic reserve for indication of hepatic resection: how I do it. J Hepato Biliary Pancreat Surg 12:31–37CrossRef Poon RT, Fan ST (2005) Assessment of hepatic reserve for indication of hepatic resection: how I do it. J Hepato Biliary Pancreat Surg 12:31–37CrossRef
33.
go back to reference Dinant S, de Graaf W, Verwer BJ et al (2007) Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med 48:685–692PubMedCrossRef Dinant S, de Graaf W, Verwer BJ et al (2007) Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med 48:685–692PubMedCrossRef
34.
go back to reference Cieslak KP, Bennink RJ, de Graaf W et al (2016) Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection. HPB (Oxford) 18:773–780CrossRef Cieslak KP, Bennink RJ, de Graaf W et al (2016) Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection. HPB (Oxford) 18:773–780CrossRef
35.
go back to reference Saito K, Ledsam J, Sourbron S et al (2014) Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention. Eur Radiol 24:112–119PubMedCrossRef Saito K, Ledsam J, Sourbron S et al (2014) Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention. Eur Radiol 24:112–119PubMedCrossRef
36.
go back to reference Sourbron S, Sommer WH, Reiser MF, Zech CJ (2012) Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging. Radiology 263:874–883PubMedCrossRef Sourbron S, Sommer WH, Reiser MF, Zech CJ (2012) Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging. Radiology 263:874–883PubMedCrossRef
37.
go back to reference Geisel D, Lüdemann L, Hamm B, Denecke T (2015) Imaging-based liver function tests--past, present and future. Rofo 187:863–871PubMedCrossRef Geisel D, Lüdemann L, Hamm B, Denecke T (2015) Imaging-based liver function tests--past, present and future. Rofo 187:863–871PubMedCrossRef
38.
go back to reference Berardi G, Morise Z, Sposito C et al (2020) Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis. J Hepatol 72:75–84PubMedCrossRef Berardi G, Morise Z, Sposito C et al (2020) Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in Child-Pugh B cirrhosis. J Hepatol 72:75–84PubMedCrossRef
39.
go back to reference Donadon M, Fontana A, Palmisano A et al (2017) Individualized risk estimation for postoperative morbidity after hepatectomy: the Humanitas score. HPB (Oxford) 19:910–918CrossRef Donadon M, Fontana A, Palmisano A et al (2017) Individualized risk estimation for postoperative morbidity after hepatectomy: the Humanitas score. HPB (Oxford) 19:910–918CrossRef
40.
go back to reference Serenari M, Han KH, Ravaioli F et al (2020) A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma. J Hepatol 73:855–862PubMedCrossRef Serenari M, Han KH, Ravaioli F et al (2020) A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma. J Hepatol 73:855–862PubMedCrossRef
41.
go back to reference Kubota K, Aoki T, Kumamaru H et al (2019) Use of the National Clinical Database to evaluate the association between preoperative liver function and postoperative complications among patients undergoing hepatectomy. J Hepatobiliary Pancreat Sci 26:331–340PubMed Kubota K, Aoki T, Kumamaru H et al (2019) Use of the National Clinical Database to evaluate the association between preoperative liver function and postoperative complications among patients undergoing hepatectomy. J Hepatobiliary Pancreat Sci 26:331–340PubMed
42.
go back to reference Kim DK, Choi JI, Choi MH et al (2018) Prediction of posthepatectomy liver failure: MRI with hepatocyte-specific contrast agent versus indocyanine green clearance test. AJR Am J Roentgenol 211:580–587PubMedCrossRef Kim DK, Choi JI, Choi MH et al (2018) Prediction of posthepatectomy liver failure: MRI with hepatocyte-specific contrast agent versus indocyanine green clearance test. AJR Am J Roentgenol 211:580–587PubMedCrossRef
43.
go back to reference Serenari M, Collaud C, Alvarez FA et al (2018) Interstage assessment of remnant liver function in ALPPS using hepatobiliary scintigraphy: Prediction of posthepatectomy liver failure and introduction of the HIBA index. Ann Surg 267:1141–1147PubMedCrossRef Serenari M, Collaud C, Alvarez FA et al (2018) Interstage assessment of remnant liver function in ALPPS using hepatobiliary scintigraphy: Prediction of posthepatectomy liver failure and introduction of the HIBA index. Ann Surg 267:1141–1147PubMedCrossRef
44.
go back to reference Sørensen M, Mikkelsen KS, Frisch K, Villadsen GE, Keiding S (2013) Regional metabolic liver function measured in patients with cirrhosis by 2-[18F]fluoro-2-deoxy-D-galactose PET/CT. J Hepatol 58:1119–1124PubMedPubMedCentralCrossRef Sørensen M, Mikkelsen KS, Frisch K, Villadsen GE, Keiding S (2013) Regional metabolic liver function measured in patients with cirrhosis by 2-[18F]fluoro-2-deoxy-D-galactose PET/CT. J Hepatol 58:1119–1124PubMedPubMedCentralCrossRef
45.
go back to reference Yoon JH, Lee JM, Kim E, Okuaki T, Han JK (2017) Quantitative liver function analysis: volumetric T1 mapping with fast multisection B 1 inhomogeneity correction in hepatocyte-special contrast-enhanced liver MR imaging. Radiology 282:408–417PubMedCrossRef Yoon JH, Lee JM, Kim E, Okuaki T, Han JK (2017) Quantitative liver function analysis: volumetric T1 mapping with fast multisection B 1 inhomogeneity correction in hepatocyte-special contrast-enhanced liver MR imaging. Radiology 282:408–417PubMedCrossRef
46.
go back to reference Kudo M, Gotohda N, Sugimoto M et al (2018) Evaluation of liver function using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging based on a three-dimensional volumetric analysis system. Hepatol Int 12:368–376PubMedCrossRef Kudo M, Gotohda N, Sugimoto M et al (2018) Evaluation of liver function using gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging based on a three-dimensional volumetric analysis system. Hepatol Int 12:368–376PubMedCrossRef
47.
go back to reference Reeder SB (2019) Quantification of liver function with MRI: Is it ready? Radiology 2019(290):134–135CrossRef Reeder SB (2019) Quantification of liver function with MRI: Is it ready? Radiology 2019(290):134–135CrossRef
48.
go back to reference Rassam F, Zhang T, Cieslak KP et al (2019) Comparison between dynamic gadoxetate-enhanced MRI and 99m Tc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function. Eur Radiol 29:5063–5072PubMedPubMedCentralCrossRef Rassam F, Zhang T, Cieslak KP et al (2019) Comparison between dynamic gadoxetate-enhanced MRI and 99m Tc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function. Eur Radiol 29:5063–5072PubMedPubMedCentralCrossRef
Metadata
Title
Regional liver function analysis with gadoxetic acid–enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC
Authors
Mengqi Huang
Shunli Shen
Huasong Cai
Zhenpeng Peng
Wan Hang Keith Chiu
Zi-Ping Li
Baogang Peng
Shi-Ting Feng
Publication date
01-07-2021
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 7/2021
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-07606-x

Other articles of this Issue 7/2021

European Radiology 7/2021 Go to the issue